Thymic Carcinoma Center (EIN 862591007) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

Michael Delaney

Phone

9135222054

Tax Period

2025-01-01 to 2025-12-31

Thymic Carcinoma Center, founded in 2021, is a small nonprofit in the Diseases & Disorders sector that reported $635K in total revenue in fiscal year 2025. Revenue fell 29% from the prior year — a significant decline worth monitoring. Expenses of $576K left a modest 9% surplus.

Mission

To provide financial support to those suffering from thymic carcinomas.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $531,942

Program Service Revenue $0

Investment Income $0

Other Revenue $102,821

TOTAL REVENUE $634,763

Expense Breakdown

Grants Paid $277,046

Salaries & Benefits $250,260

Fundraising Expenses $0

Program Expenses $575,708

Other Expenses $48,402

TOTAL EXPENSES $575,708

Year-over-Year Comparison

	2025	2024	Change
Revenue	$634,763	$895,186	-0.3%
Expenses	$575,708	$1,031,237	-0.4%
Net Income	$59,055	$-136,051	-1.4%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$110,000

Total Directors

$110,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michael Delaney	President	40.00	Officer Director	$110,000	$0	$110,000
Genevieve Kiley	Secretary	0.00	Director	$0	$0	$0
Giuseppe Giacone	Treasurer	0.00	Director	$0	$0	$0
Adam Davidson	Trustee	0.00	Director	$0	$0	$0
David Low	Trustee	0.00	Director	$0	$0	$0
Joe Carter	Trustee	0.00	Director	$0	$0	$0
Julie Jaklevic	Trustee	0.00	Director	$0	$0	$0
Justine Kane	Trustee	0.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$634,763	$575,708	$391,848	$59,055
2024	$895,186	$1,031,237	$335,307	$-136,051
2023	$662,043	$495,182	$696,030	$166,861
2022	$636,838	$245,682	$568,715	$391,156
2021	$249,112	$76,456	$172,656	$172,656
2021	$249,112	$78,169	$170,943	$170,943

Thymic Carcinoma Center